DK2340035T3 - Behandling af fruktosemalabsorption - Google Patents

Behandling af fruktosemalabsorption

Info

Publication number
DK2340035T3
DK2340035T3 DK09775597.9T DK09775597T DK2340035T3 DK 2340035 T3 DK2340035 T3 DK 2340035T3 DK 09775597 T DK09775597 T DK 09775597T DK 2340035 T3 DK2340035 T3 DK 2340035T3
Authority
DK
Denmark
Prior art keywords
treatment
fructose malabsorption
malabsorption
fructose
Prior art date
Application number
DK09775597.9T
Other languages
English (en)
Inventor
Albert Missbichler
Original Assignee
Sciotec Diagnostic Technologies Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41429246&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2340035(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP08450128A external-priority patent/EP2161034A1/de
Application filed by Sciotec Diagnostic Technologies Gmbh filed Critical Sciotec Diagnostic Technologies Gmbh
Application granted granted Critical
Publication of DK2340035T3 publication Critical patent/DK2340035T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/52—Isomerases (5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/32—Manganese; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y503/00—Intramolecular oxidoreductases (5.3)
    • C12Y503/01—Intramolecular oxidoreductases (5.3) interconverting aldoses and ketoses (5.3.1)
    • C12Y503/01005—Xylose isomerase (5.3.1.5)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Diabetes (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK09775597.9T 2008-09-04 2009-08-19 Behandling af fruktosemalabsorption DK2340035T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
AT13802008 2008-09-04
EP08450128A EP2161034A1 (de) 2008-09-04 2008-09-04 Behandlung von Fruktose-Malabsorption
PCT/AT2009/000314 WO2010025483A1 (de) 2008-09-04 2009-08-19 Behandlung von fruktose-malabsorption

Publications (1)

Publication Number Publication Date
DK2340035T3 true DK2340035T3 (da) 2014-10-20

Family

ID=41429246

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09775597.9T DK2340035T3 (da) 2008-09-04 2009-08-19 Behandling af fruktosemalabsorption

Country Status (10)

Country Link
US (1) US9144602B2 (da)
EP (3) EP3269383A1 (da)
CA (1) CA2735465C (da)
DK (1) DK2340035T3 (da)
ES (1) ES2515215T3 (da)
PL (1) PL2340035T3 (da)
PT (1) PT2340035E (da)
SI (1) SI2340035T1 (da)
TW (1) TWI526221B (da)
WO (1) WO2010025483A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2340035T3 (da) 2008-09-04 2014-10-20 Sciotec Diagnostic Technologies Gmbh Behandling af fruktosemalabsorption
US20170056485A1 (en) * 2015-08-31 2017-03-02 Sciotec Diagnostic Technologies Gmbh Crystallized xylose isomerase in prevention of the development of non-alcoholic fatty liver disease
WO2023019266A2 (en) * 2021-08-13 2023-02-16 Anagram Therapeutics, Inc. Methods and compositions for treating fructose intolerance and fructose malabsorption

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3847740A (en) * 1972-10-02 1974-11-12 Cpc International Inc Process for the production of levulose-bearing syrups
DK8502857A (da) * 1984-06-25 1985-12-26
US4699822A (en) 1985-08-30 1987-10-13 W. R. Grace & Co. Fireproofed metal structural members and method of fabricating same
FI85285C (fi) 1988-05-13 1992-03-25 Stabra Ag Tvaerbundet, vattenoloesligt glukosisomeras och foerfarande foer framstaellning daerav.
US5120650A (en) 1989-10-13 1992-06-09 Stabra Ag Method for producing crystalline glucose isomerase
AU6574400A (en) * 1999-08-18 2001-03-13 Hydrios Biotechnology Oy Process for the preparation and simultaneous separation of enzyme-catalysed products
FI115293B (fi) 2002-05-29 2005-04-15 Teknillinen Korkeakoulu Nukleosidien erotus käyttäen kiinteää, ristisidottua ksyloosi-isomeraasia
DE102006013624B4 (de) 2005-11-23 2012-03-15 Pro Natura Gesellschaft für gesunde Ernährung mbH Mittel zur Anwendung bei Fructoseintoleranz
KR20080080122A (ko) 2005-11-16 2008-09-02 프로 나투라 게셀챠프트 퓌르 게순드 에르나룽 엠브릿지홀딩스 프럭토즈 비내성의 경우에 사용하기 위한 약제
EP1951293B1 (en) * 2005-11-23 2015-09-09 Pro Natura Gesellschaft für Gesunde Ernährung mbH Agent for use in the case of disorders of blood sugar metabolism, including diabetes
DE102007008664B4 (de) 2007-02-20 2021-07-29 Vitacare Gmbh & Co. Kg Mittel zur Anwendung bei Fructoseintoleranz
DK2340035T3 (da) 2008-09-04 2014-10-20 Sciotec Diagnostic Technologies Gmbh Behandling af fruktosemalabsorption

Also Published As

Publication number Publication date
PT2340035E (pt) 2014-10-20
WO2010025483A1 (de) 2010-03-11
EP3269383A1 (de) 2018-01-17
US20110165231A1 (en) 2011-07-07
SI2340035T1 (sl) 2014-12-31
CA2735465C (en) 2023-03-21
US9144602B2 (en) 2015-09-29
WO2010025483A8 (de) 2010-05-14
TW201012474A (en) 2010-04-01
TWI526221B (zh) 2016-03-21
EP2764872A1 (de) 2014-08-13
EP2340035B1 (de) 2014-07-16
ES2515215T3 (es) 2014-10-29
CA2735465A1 (en) 2010-03-11
PL2340035T3 (pl) 2015-02-27
EP2340035A1 (de) 2011-07-06

Similar Documents

Publication Publication Date Title
DK3192520T3 (da) Terapeutiske midler til reducering af niveauerne af parathyreoideahormon
DK2240130T3 (da) Indretning til behandling af fedme
DK2350116T3 (da) Behandling af biofilm
DK3289876T3 (da) Forbindelser til behandling af cancer
DK2982696T3 (da) Behandling af akut lymfoblastær leukæmi
DK2293816T3 (da) Fremgangsmåder til behandling af reumatoid arthritis
DK2498771T3 (da) Anvendelse af bethanechol til behandling af xerostomi
DK2111555T3 (da) Diagnosticering af præeklampsi
DK3412687T3 (da) Fremgangsmåder til behandling af dlbcl
DK2300560T3 (da) Termisk behandling af biomasse
DK2271642T3 (da) Pyridylinhibitorer af hedgehog signalering
DK2276496T3 (da) Terapeutisk modulering af øjenoverfladebefugtning
DK3509341T3 (da) Tilpasning af overgivelsesparametre
DK2211747T3 (da) Indretninger til refraktiv behandling af presbyopi
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2262793T3 (da) Krystallinske former af nilotinib-hci
DK2254591T3 (da) Inhibering eller behandling af gastrointestinal biofilm
DK2509684T3 (da) Anordning til behandling af rhinitis ved biostimulerende belysning
DK2252317T3 (da) Behandling af makuladegeneration
DK2358714T3 (da) Alkylcyclohexylethere af dihydrotetraazabenzoazulener
DK2342346T3 (da) Thermotoga til behandling af biomasse
DK2459129T3 (da) Forbedringer af karstøtteanordninger
DK3284820T3 (da) Fremgangsmåde til behandling af pyropheophytin-holdige sammensætninger
PL2506850T3 (pl) Sposoby podawania terapii pirfenidonem
DK2382232T3 (da) Fremgangsmåde til fremstilling af bivalirudin